Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need.
$1.02+0.99%
报价 2026-11-16
市值
$92M
EV
$93.1M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -36.3%
$0.94$1.60
筛选结果
pipeline · 2026-11-16Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| VANIVivani Medical, Inc. | $92M | +1.0% | -100.0% | 0% | – | – | – | |
| RCELAVITA Medical, Inc. | $378.1M | -2.6% | – | 81.6% | – | – | – | |
| ORMPOramed Pharmaceuticals Inc. | $169.6M | +5.1% | -40.0% | 0% | 1.9x | 2.4x | – | |
| CRDLCardiol Therapeutics Inc. | $118.2M | -2.0% | – | 0% | – | – | – | |
| HYPRHyperfine, Inc. | $55.5M | -3.1% | +50.7% | 51.4% | – | – | – | |
| MBOTMicrobot Medical Inc. | $43.3M | -34.2% | +4900.0% | -9.5% | – | – | – | |
| IMAImageneBio Inc | $36.3M | -7.8% | 0.0% | 0% | – | – | – | |
| NSPRInspireMD, Inc. | $27.9M | -6.8% | – | 18.1% | – | – | – | |
| 同行中位数 | – | – | +25.4% | 0% | 1.9x | 2.4x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。